Effects of GBA1 Variants and Prenatal Exposition on the Glucosylsphingosine (Lyso-Gb1) Levels in Gaucher Disease Carriers
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212021 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Paulina Szymańska-Rożek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, 02-097 Warsaw, Poland. Hauptthemen laut MEDLINE: Gaucher Disease, Glucosylceramidase, Psychosine, Heterozygote. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gaucher disease (GD) is a lysosomal lipid storage disorder caused by β-glucocerebrosidase (encoded by GBA1 gene) activity deficiency, resulting in the accumulation of glucosylceramide (Gb1) and its deacylated metabolite glucosylsphingosine (lyso-Gb1). Lyso-Gb1 has been studied previously and proved to be a sensitive biomarker, distinguishing patients with GD from carriers and healthy subjects. It was shown that its level corresponds with β-glucocerebrosidase activity, thus it remains unknown as to why carriers have slightly higher lyso-Gb1 level than healthy population. This is the first report on lyso-Gb1 levels describing representative cohort of GD carriers. Our data of 48 GD carriers, including three newborns, indicated that there are significant differences in lyso-Gb1 levels between carriers having a GD-affected mother and a healthy mother (11.53 and 8.45, respectively, p = 0.00077), and between carriers of the L483P GBA1 variant and carriers of other GBA1 pathogenic variants (9.85 and 7.03, respectively, p = 0.07). Through analysing our unique data of three newborns whose mothers are patients with GD, we also found that lyso-Gb1 is most probably transferred to the foetus via placenta.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Mathematics, Informatics and Mechanics, University of Warsaw, 02-097 Warsaw, Poland.
- Institute of Clinical Sciences, Maria Skłodowska-Curie Medical Academy, 00-136 Warsaw, Poland.
- Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.
- Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, 15-089 Bialystok, Poland.
- Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
ORCID-Profile: Patryk Lipiński, Paweł Dubiela, Anna Tylki-Szymańska
Zitieren
APA
Szymańska-Rożek, P., Lipiński, P., Kleinotiene, G., Dubiela, P., & Tylki-Szymańska, A. (2024). Effects of GBA1 Variants and Prenatal Exposition on the Glucosylsphingosine (Lyso-Gb1) Levels in Gaucher Disease Carriers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212021
Vancouver
Szymańska-Rożek P, Lipiński P, Kleinotiene G, Dubiela P, Tylki-Szymańska A. Effects of GBA1 Variants and Prenatal Exposition on the Glucosylsphingosine (Lyso-Gb1) Levels in Gaucher Disease Carriers. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212021
BibTeX
@article{SzymaskaRoek2024,
author = {Szymańska-Rożek, Paulina and Lipiński, Patryk and Kleinotiene, Grazina and Dubiela, Paweł and Tylki-Szymańska, Anna},
title = {Effects of GBA1 Variants and Prenatal Exposition on the Glucosylsphingosine (Lyso-Gb1) Levels in Gaucher Disease Carriers},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212021}
}
EUVIMED